Endomyocardial fibrosis: Still a mystery after 60 years

PLoS Neglected Tropical Diseases

Volumn 2, Issue 2, 2008, Pages

  Bukhman, Gene ^a   Ziegler, John ^b   Parry, Eldryd ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

CLINICAL FEATURE; CLINICAL RESEARCH; ECHOCARDIOGRAPHY; GEOGRAPHIC DISTRIBUTION; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HUMAN; MEDLINE; MORBIDITY; MYOCARDITIS; NONHUMAN; PATHOPHYSIOLOGY; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SPLENOMEGALY; ANIMAL; PATHOLOGY;

ANIMALS; ECHOCARDIOGRAPHY; ENDOMYOCARDIAL FIBROSIS; HUMANS;

EID: 48949117602     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000097     Document Type: Review

References (112)

1. Davies JNP (1948) Endomyocardial fibrosis in Uganda. East Afr Med J 25: 10-16.
2. Ball JD, Williams AW, Davies JN (1954) Endomyocardial fibrosis. Lancet 266: 1049-1054.
3. Connor DH, Somers K, Hutt MS, Manion WC, D'Arbela PG (1967) Endomyocardial fibrosis in Uganda (Davies' disease). 1. An epidemiologic, clinical, and pathologic study. Am Heart J 74: 687-709.
4. Williams A (1938) Heart disease in the native population of Uganda. East African Medical Journal 15: 279.
5. Hutt MS (1983) Epidemiology aspects of endomyocardial fibrosis. Postgrad Med J 59: 142-146.
6. Lopez AD, Disease Control Priorities Project (2006) Global burden of disease and risk factors. New York: Oxford University Press.
7. McKenna W, Nordet P, Martin I, Gyarfas I, Thiene G, et al. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93: 841-842.
8. Freers J, Hakim J, Myanja-Kizza H, Party E (2004) The heart. In: Parry E, Godfrey R, Mabey D, Gill G, eds. Principles of medicine in Africa. Cambridge: Cambridge University Press. pp 837-886.
9. D'Arbela PG, Mutazindwa T, Patel AK, Somers K (1972) Survival after first presentation with endomyocardial fibrosis. Br Heart J 34: 403-407.
10. Barretto AC, da Luz PL, de Oliveira SA, Stolf NA, Mady C, et al. (1989) Determinants of survival in endomyocardial fibrosis. Circulation 80: 1177-182.
11. Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK (1989) Clinical course of endomyocardial fibrosis. Br Heart J 62: 450-454.
12. Parry EH, Abrahams DG (1965) The natural history of endomyocardial fibrosis. QJ Med 34: 383-408.
13. Moraes F, Lapa C, Hazin S, Tenorio E, Gomes C, et al. (1999) Surgery for endomyocardial fibrosis revisited. Eur J Cardiothorac Surg 15: 309-312; discussion 312-303.
14. Schneider U, Jenhi R, Turina J, Turina M, Hess OM (1998) Long-term follow up of patients with endomyocardial fibrosis: effects of surgery Heart 79: 362-367.
15. Metras D, Coulibaly AQ, Ouattara K (1987) Recent trends in the surgical treatment of endomyocardial fibrosis. J Cardiovasc Surg (Torino) 28: 607-613.
16. Cherian SM, Jagannath BR, Nayar S, Cherian KM (2006) Successful reoperation after 17 years in a case of endomyocardial fibrosis. Ann Thorac Surg 82: 1115-1117.
17. Dubost C, Prigent C, Gerbaux A, Maurice P, Passelecq J, et al. (1983) Surgical approaches in endomyocardial disease. Postgrad Med J 59: 160-161.
18. Obituaries (1998) Jack Neville Phillip Davies. BMJ 317: 1662.
19. Corssmit EP, Trip MD, Durrer JD (1999) Loffler's endomyocarditis in the idiopathic hypereosinophilic syndrome. Cardiology 91: 272-276.
20. Löffler W (1936) Endocarditis parietalis fibroplastica mit Bluteosinophilic. J Suisse Med 66: 817-820.
21. Falase AO (1985) Are eosinophils the cause of endomyocardial fibrosis in the tropics? Afr J Med Med Sci 14: 1-2.
22. Shaper AG (1993) What's new in endomyocardial fibrosis? Lancet 342: 255-256.
23. Valiathan SM, Kartha CC (1990) Endomyocardial fibrosis - the possible connexion with myocardial levels of magnesium and cerium. Int J Cardiol 28: 1-5.
24. Patel AK, D'Arbela PG, Somers K (1977) Endomyocardial fibrosis and eosinophilia. Br Heart J 39: 238-241.
25. Williams AW, Ball JD, Davies JN (1954) Endomyocardial fibrosis in Africa: its diagnosis, distribution and nature. Trans R Soc Trop Med Hyg 48: 290-305; discussion, 306-211.
26. Hassan WM, Fawzy ME, Al Helaly S, Hegazy H, Malik S (2005) Pitfalls in diagnosis and clinical, echocardiographic, and hemodynamic findings in endomyocardial fibrosis: a 25-year experience. Chest 128: 3985-3992.
27. Bertrand E, Cherian G, Das S, Dubost C, Falase A, et al. (1984) Cardiomyopathies. Technical report series 697. Geneva: World Health Organization.
28. Acquatella H, Schiller NB, Puigbo JJ, Gomez-Mancebo JR, Suarez C, et al. (1983) Value of two-dimensional echocardiography in endomyocardial disease with and without eosinophilia. A clinical and pathologic study. Circulation 67: 1219-1226.
29. Bedford DE, Konstam GLS (1946) Heart failure of unknown actilogy in Africans. Brit Heart J 8: 236.
30. Rutakingirwa M, Ziegler JL, Newton R, Freers J (1999) Poverty and eosinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda. Trop Med Int Health 4: 229-235.
31. Davies J, Spry CJ, Vijayaraghavan G, De Souza JA (1983) A comparison of the clinical and cardiological features of endomyocardial disease in temperate and tropical regions. Postgrad Med J 59: 179-185.
32. Falase AO (1983) Endomyocardial fibrosis in Africa. Postgrad Med J 59: 170-178.
33. Ferreira B, Matsika-Claquin MD, Hausse-Mocumbi AO, Sidi D, Paquet C (2002) [Geographic origin of endomyocardial fibrosis treated at the central hospital of Maputo (Mozambique) between 1987 and 1999]. Bull Soc Pathol Exot 95: 276-279.
34. Makene WJ (1970) Endomyocardial fibrosis in Tanzania (mainland). East Afr Med J 47: 91-96.
35. Rees P (1969) The occurrence and recognition of endomyocardial fibrosis of the right ventricle in coastal Tanzania. Trans R Soc Trop Med Hyg 63: 650-655.
36. Nwokolo C (1955) Endomyocardial fibrosis and other obscure cardiopathies in eastern Nigeria. West Afr Med J 4: 103-116.
37. Ladipo GO, Froude JR, Parry EH (1977) Pattern of heart disease in adults of the Nigerian savanna: a prospective clinical study. Afr J Med Med Sci 6: 185-192.
38. Abrahams DG (1962) Endomyocardial fibrosis of the right ventricle. Q J Med 31: 1-20.
39. Abraham DG (1959) An unusual form of heart-disease in West Africa; its relation to endomyocardial fibrosis. Lancet 2: 111-112.
40. Yin R (2000) Endomyocardial fibrosis in China. Chin Med Sci J 15: 55-60.
41. Berensztein CS, Pineiro D, Marcutegui M, Brunoldi R, Blanco MV, et al. (2000) Usefulness of echocardiography and doppler echocardiography in endomyocardial fibrosis. J Am Soc Echocardiogr 13: 385-392.
42. Freers J, Mayanja-Kizza H, Rutakingirwa M, Gerwing E (1996) Endomyocardial fibrosis: why is there striking ascites with little or no peripheral oedema? Lancet 347: 197.
43. Vijayaraghavan G, Davies J, Sadanandan S, Spry CJ, Gibson DG, et al. (1983) Echocardiographic features of tropical endomyocardial disease in South India. Br Heart J 50: 450-459.
44. Maro E, Janabi M (2004) Echocardiographic profile of endomyocardial fibrosis in Tanzania, East Africa. Cent Afr J Med 50: 91-94.
45. Cockshott WP, Saric S, Ikeme AC (1967) Radiological findings in endomyocardial fibrosis. Circulation 35: 913-922.
46. Andy JJ, Ogunowo PO, Akpan NA, Odigwe CO, Ekanem IA, et al. (1998) Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Trop 69: 127-140.
47. Sliwa K, Damasceno A, Mayosi BM (2005) Epidemiology and etiology of cardiomyopathy in Africa. Circulation 112: 3577-3583.
48. Shaper AG (1967) Plantain diets, serotonin, and endomyocardial fibrosis. Am Heart J 73: 432-434.
49. McKinney B, Crawford MA (1965) Fibrosis in guinea pig heart produced by plantain diet. Lancet 2: 880-882.
50. Crawford MA (1963) Endomyocardial fibrosis and carcinoidosis. A common denominator? Am Heart J 66: 273-276.
51. Crawford MA (1962) Excretion of 5-hydroxyindolylacetic acid in East Africans. Lancet 1: 352-353.
52. Foy JM, Parrat JR (1962) Urinary excretion of 5-hydroxyindoleacetic acid in West Africans. Lancet 1: 942-943.
53. McKinney B (1976) Endocardial changes produced in Patus monkeys by the ablation of cardiac lymphatics and the administration of a plantain diet. Am Heart J 91: 484-491.
54. McKinney B (1975) Studies on the experimental production of endomyocardial fibrosis and cardiomegaly of unknown origin by dietary means. Am Heart J 90: 206-214.
55. Ojo GO (1970) The pathogenesis of endomyocardial fibrosis: the question of 5-hydroxytryptamine. Br Heart J 32: 671-674.
56. Edge J (1946) Myocardial fibrosis following arsenical therapy: report of a case. Lancet 248: 675-677.
57. Gray IR (1951) Endocardial fibrosis. Br Heart J 13: 387-396.
58. Clark GM, Valentine E, Blount SG Jr (1956) Endocardial fibrosis simulating constrictive pericarditis; report of a case with determinations of pressure in the right side of the heart and cosinophilia. N Engl J Med 254: 349-355.
59. Giraud G, Latour H, Puech P, Olivier G, Hertault J (1958) Cardiopathie filarienne: etude hemodynamique. Arch Mal Coeur Vaiss 51: 546-557.
60. Fournier P, Voisin C, Pauchant M, Macquet V (1961) [Parietal fibroplastic endocarditis and filariasis. Clinical, hemodynamic and anatomical study.]. Lille Med 6: 42-47.
61. Brockington IF, Olsen EG, Goodwin JF (1967) Endomyocardial fibrosis in Europeans resident in tropical Afirica. Lancet 1: 583-588.
62. Ive FA, Willis AJ, Ikerne AC, Brockington IF (1967) Endomyocardial fibrosis and filariasis. Q J Med 36: 495-516.
63. Ive F, Brockington I (1966) Endomyocardial fibrosis and filariasis. Lancet 69: 212.
64. Nutman TB, Miller KD, Mulligan M, Ottesen EA (1986) Loa loa infection in temporary residents of endemic regions: recognition of a hyparesponsive syndrome with characteristic clinical manifestations. J Infect Dis 154: 10-18.
65. Berenguer A, Plancha E, Munoz Gil J (2003) Right ventricular endomyocardial fibrosis and microfilarial infection. Int J Cardiol 87: 287-289.
66. Brockington IF, Olsen EG (1973) Löffler's endocarditis and Davies' endomyocardial fibrosis. Am Heart J 85: 308-322.
67. Olsen EG (1983) Pathological aspects of endomyocardial fibrosis. Postgrad Med J 59: 135-141.
68. Patel AK, Ziegler JL, D'Arbela PG, Somers K (1971) Familial cases of endomyocardial fibrosis in Uganda. Br Med J 4: 331-334.
69. Carlisle R, Ogunba EO, McFarlane H, Onayemi OA, Oyeleye VO (1972) Immunoglobulins and antibody to Loa loa in Nigerians with endomyocardial fibrosis and other heart diseases. Br Heart J 34: 678-680.
70. Urhoghide GE, Falase AO (1987) Degranulated eosinophils, eosinophil granule basic proteins mid humoral factors in Nigerians with endomyocardial fibrosis. Afr J Med Med Sci 16: 133-139.
71. Wilson AM, Weller PF (2006) Eosinophilia. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens & practice. 2nd edition. Philadelphia: Churchill Livingstone. pp 1478-1495.
72. Fett JD, Christie LG, Carraway RD, Murphy JG (2005) Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin Proc 80: 1602-1606.
73. Shaper AG, Coles RM (1965) The Tribal distribution of endomyocardial fibrosis in Uganda. Br Heart J 27: 121-127.
74. Shaper AG, Kaplan MH, Foster WD, Macintosh DM, Wilks NE (1967) Immunological studies in endomyocardial fibrosis and other forms of heart-disease in the tropics. Lancet 1: 598-600.
75. Shaper AG, Kaplan MH, Mody NJ, McIntyre PA (1968) Malarial antibodies and autoantibodies to heart and other tissues in the immigrant and indigenous peoples of Uganda. Lancet 1: 1342-1346.
76. van der Geld H, Peetoom F, Somers K, Kanyerezi BR (1966) Immunohistological and serological studies in endomyocardial fibrosis. Lancet 2: 1210-1213.
77. Bedu-Addo G, Bates I (2002) Causes of massive tropical splenomegaly in Ghana. Lancet 360: 449-454.
78. Kutty VR, Abraham S, Kartha CC (1996) Geographical distribution of endomyocardial fibrosis in south Kerala. Int J Epidentiol 25: 1202-1207.
79. Sezi CL (1996) Effect of protein deficient cassava diet on Cercopithecus aethiops hearts and its possible role in the aetiology and pathogenesis of endomyocardial fibrosis in man. East Afr Med J 73: S11-S16.
80. Tylleskar T, Banca M, Bikangi N, Cooke RD, Poulter NH, et al. (1992) Cassava cyanogens and konzo, an upper motoneuron disease found in Africa. Lancet 339: 208-211.
81. Cools J, DtAngelo DJ, Gotlib J, Stover EH, Legate RD, et al. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348: 1201-1214.
82. Sliwa K, Fett J, Elkayam U (2006) Peripartum cardiomyopathy. Lancet 368: 687-693.
83. Boehme SA, Lio FM, Sikora L, Pandit TS, Lavrador K, et al. (2004) Cutting edge: serotonin is a chemotactic factor for eosinophils and functions additively with eotaxin. J Immunol 173: 3599-3603.
84. Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, et al. (2007) Valvular heart disease and the use of dopamme agonists for Parkinson's disease. N Engl J Med 356: 39-46.
85. Ijaola O, Falase AO (1990) Distribution of antibodies against Coxsackie B viruses, arboviruses and Toxoplasma gondii among patients with endomyocardial fibrosis (EMF) compared with normal subjects from EMF endemic and non-endernic zones of Nigeria. Afr J Med Med Sci 19: 93-103.
86. Shaper AG (1966) Endomyocardial fibrosis and rheumatic heart-disease. Lancet 1: 639-641.
87. Eling WM, Jerusalem CR, Heinen-Borries UJ, Hermsen CC, van Run-van Breda JJ (1988) Is malaria involved in the pathogenesis of tropical endomyocardial fibrosis? Acta Leiden 57: 47-52.
88. Shaper AG (1972) Cartrovascular disease in the tropics. II. Endomyocardial fibrosis. Br Med J 3: 743-746.
89. Jaiyesimi F (1982) Controversies and advances in endomyocardial fibrosis: a review. Afr J Med Med Sci 11: 37-46.
90. Brockington IF, Olsen EG (1972) Eosinophilia and endomyocardial fibrosis. Postgrad Med J 48: 740-741.
91. Davies H (1990) Endomyocardial fibrosis and the tuberous diet. Int J Cardiol 29: 3-8.
92. Connor DH, Somers K, Hutt MS, Manion WC, D'Arbela PG (1968) Endomyocardial fibrosis in Uganda (Davies' disease). 2. An epidemiologic, clinical, and pathologic study. Am Heart J 75: 107-124.
93. Abrahams DG (1962) Endomyocardial fibrosis of the right ventricle. Quart J Med 31: 1-20.
94. Nkowolo C (1968) Correspondence. Experimental production of endomyocardial fibrosis. Lancet 272: 102.
95. Bertrand E, Renambot J, Chauvet J, Le Bras M, Lamouche P, et al. (1975) [14 cases of constrictive endocardial fibrosis (or endomyocardial fibrosis]. Arch Mal Coeur Vaiss 68: 625-635.
96. Amoah AG, Kallen C (2000) Aetiology of heart failure as seen from a National Cardiac Referral Centre in Africa. Cardiology 93: 11-18.
97. Kimbally-Kaky G, Ekoba J, Nkoua JL, Bouramoue C (2000) [Endomyocardial fibrosis: report of 22 Congolese cases]. Ann Cardiol Angeiol (Paris) 49: 287-295.
98. Turner PP, Manson-Bahr PE (1960) Endomyocardial fibrosis in Kenya and Tanganyika Africans. Br Heart J 22: 305-310.
99. Kingue S, Dzudie A, Mehanga A, Akono M, Ouankou M, et al. (2005) [A new look at adult chronic heart failure in Africa in the age of the Doppler echocardiography: experience of the medicine department at Yaounde General Hospital]. Ann Cardiol Angeiol (Paris) 54: 276-283.
100. Maru M (1993) The changing pattern of cardiovascular diseases in Ethiopia. East Afr Med J 70: 772-776.
101. Sachs JD, Amoako KY, Aninat E, Diabre DCZ, Doryan E, et al. (2001) Macrocconomics and health: investing in health for economic development. Geneva: World Health Organization.
102. Hodes RM (1988) Pattern of heart disease in Ethiopia as seen in a cardiology referral clinic. Cardiology 75: 458-464.
103. Harting D, Marsden P, Ridley D (1965) Some observations on the pattern of heart disease in the gambia. Trans R Soc Trop Med Hyg 59: 628-641.
104. Oyoo GO, Ogola EN (1999) Clinical and socio demographic aspects of congestive heart failure patients at Kenyatta National Hospital, Nairobi. East Afr Med J 76: 23-27.
105. Diallo B, Sanogo K, Diakite S, Diarra M, Toure M (2004) L'insuffisance cardiaque a Phopital do point G. Mali Med 19: 15-17.
106. Thiam M (2002) L'insuffisance cardiaque en milieu cardiologique africain. Bull Soc Pathol Exot 96: 217-218.
107. Steenekamp JH, Simson IW, Theron W (1992) Cardiovascular causes of death at Tshepong Hospital in 1 year, 1989-1990. A necropsy study. S Afr Med J 81: 142-146.
108. Richter J, Dengler A, Mohammed EG, Ali GM, Abdel-Rahim I, et al. (1990) Results of echocardiographic examinations in a regional hospital of central Sudan. Trans R Soc Trop Med Hyg 84: 749-752.
109. Guimaraes A (1993) Natural history and current status in Brazil. In: Valiathan M, Somers K, Kartha CC, eds. Endomyocardial fibrosis. Delhi: Oxford University Press. pp 37-54.
110. Suarez J, Suarez C (1973) Fibrosis endomiocardica: estudio morfologico de 5 casos. Arch Inst Cardiol Mex 43: 58-67.
111. Datta BN, Babu SK, Khattri HN, Bidwai PS, Wahi PL (1977) Endomyocardial fibrosis in Chandigarh area, India. A study of nine autopsies. Trop Geogr Med 29: 346-352.
112. Rashwan MA, Ayman M, Ashour S, Hassanin MM, Zeina AA (1995) Endomyocardial fibrosis in Egypt: an illustrated review. Br Heart J 73: 284-289.